Holen Sie sich die Stockscreener-App
91.88
0.01%
-0.01
Handel nachbörslich:
91.88
Schlusskurs vom Vortag:
$91.89
Offen:
$91.89
24-Stunden-Volumen:
241.67K
Relative Volume:
0.56
Marktkapitalisierung:
$1.99B
Einnahmen:
$486.82M
Nettoeinkommen (Verlust:
$18.78M
KGV:
112.05
EPS:
0.82
Netto-Cashflow:
$100.45M
1W Leistung:
+1.39%
1M Leistung:
+36.16%
6M Leistung:
+68.34%
1J Leistung:
+45.26%
1-Tages-Spanne:
$91.52
$92.62
1-Wochen-Bereich:
$89.29
$92.65
52-Wochen-Spanne:
$52.50
$92.65
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
91.88 | 1.99B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
155.37 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.86 | 46.99B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.71 | 43.17B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.05 | 20.82B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
305.35 | 13.98B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Trend analysis for ANI Pharmaceuticals Inc. this weekMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - Newser
Can trapped investors hope for a rebound in ANI Pharmaceuticals Inc.Quarterly Profit Report & Pattern Based Trade Signal System - Newser
How to monitor ANI Pharmaceuticals Inc. with trend dashboardsJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - Newser
Pattern recognition hints at ANI Pharmaceuticals Inc. upsideJuly 2025 PreEarnings & Verified Swing Trading Watchlists - Newser
Can ANI Pharmaceuticals Inc. Overcome Bearish SentimentJuly 2025 Technicals & Capital Protection Trade Alerts - beatles.ru
Using R and stats models for ANI Pharmaceuticals Inc. forecasting2025 Major Catalysts & Pattern Based Trade Signal System - Newser
ANI Pharmaceuticals Director Sells 2,528 Shares for $90.62 Each on August 25, 2025. - AInvest
What MACD signals say about ANI Pharmaceuticals Inc.2025 Price Action Summary & Comprehensive Market Scan Insights - Newser
How to interpret RSI for ANI Pharmaceuticals Inc. stock2025 Short Interest & Real-Time Chart Pattern Alerts - Newser
Can a trend reversal in ANI Pharmaceuticals Inc. lead to recovery2025 Technical Overview & High Accuracy Trade Alerts - Newser
Flexential Boosts Audience Engagement with ON24 AI Capabilities - AInvest
ANI Pharmaceuticals to Present at Upcoming Investor Conferences in September 2025. - AInvest
ANI Pharmaceuticals Inc. stock outlook for YEARInflation Watch & Technical Pattern Alert System - Newser
Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Day Trade & AI Driven Stock Price Forecasts - Newser
Exit strategy if you’re trapped in ANI Pharmaceuticals Inc.Earnings Miss & Safe Swing Trade Setups - Newser
What machine learning models say about ANI Pharmaceuticals Inc.Weekly Profit Report & Expert Approved Momentum Trade Ideas - Newser
Is ANI Pharmaceuticals Inc. forming a reversal patternJuly 2025 Opening Moves & Daily Momentum Trading Reports - Newser
How high can ANI Pharmaceuticals Inc. stock go2025 Trade Ideas & Daily Profit Focused Stock Screening - Newser
ANI Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewswire
Back-to-Back Healthcare Conferences: ANI Pharmaceuticals Leadership to Present at Morgan Stanley, H.C. Wainwright - Stock Titan
What Technical Tools Say About ANI Pharmaceuticals Inc. Recovery2025 Trade Ideas & Consistent Profit Alerts - newsyoung.net
What Fibonacci levels say about ANI Pharmaceuticals Inc. rebound2025 Top Gainers & Daily Volume Surge Signals - Newser
When is the best time to exit ANI Pharmaceuticals Inc.Bear Alert & Momentum Based Trading Ideas - Newser
Momentum Screeners Rank ANI Pharmaceuticals Inc. in Top 5 Today2025 Support & Resistance & Consistent Profit Focused Trading Strategies - beatles.ru
Amarin Stock Surges Amid Medical Sector Growth - AInvest
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run? - ca.finance.yahoo.com
RSI Reset May Fuel Rebound in ANI Pharmaceuticals Inc.2025 Pullback Review & AI Powered Market Entry Ideas - beatles.ru
ANI Pharmaceuticals Inc. recovery potential after sell offCPI Data & Long-Term Growth Plans - Newser
MACD Signals Flash Warning for ANI Pharmaceuticals Inc. StockMarket Performance Recap & Fast Entry High Yield Tips - newsyoung.net
Detecting price anomalies in ANI Pharmaceuticals Inc. with AIJuly 2025 Movers & Technical Pattern Based Buy Signals - Newser
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals Executives Sell Shares Amid Market Volatility - AInvest
ANI Pharmaceuticals' Insider Sales: Strategic Liquidity or a Warning Signal for Shareholders? - AInvest
Insider Selling at ANI Pharmaceuticals: A Cautionary Signal Amidst Strong Earnings and Analyst Optimism? - AInvest
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock - Investing.com
Ani Pharmaceuticals Insider Sold Shares Worth $801,450, According to a Recent SEC Filing - MarketScreener
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock By Investing.com - Investing.com UK
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD - Investing.com India
Will ANI Pharmaceuticals Inc. Hold Gains Into CloseMarket Weekly Review & Consistent Income Trade Ideas - newsimpact.co.kr
ANI gets FDA approval for generic Motegrity - MSN
ANI Pharmaceuticals, Berkshire Hathaway, Chevron - TradingView
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):